Investors choose Midcap stocks based on their risk tolerance, growth expectations, and the desire for a diversified investment portfolio that balances risk and potential returns.
Foreign Institutional Investors (FIIs) increasing their holding stake in certain companies indicate a positive outlook on the company’s performance, management, and prospects, thereby leading to speculation of expected future growth and upcoming changes in the company
Listed below are three such Midcap stocks in which Foreign Institutional Investors (FIIs) have consistently increased their stake in the past three quarters:
J K Cement Limited
With a market capitalization of Rs 30,175 crores, the stocks of J K Cement Limited, engaged in the manufacturing and selling cement and other cement-related products, started their trading session on Friday at Rs 3,850.30 and closed at Rs 3,906.10, gaining approximately 1.46 percent compared to the previous close of Rs 3,849.85 apiece.
During the recent financial quarters, the company’s basic business parameters, viz, its operating revenues as well as after-tax profits, reported movements in opposing directions with the former, on one end, increasing from Rs 2,935 crores during Q3FY24 to Rs 3,106 crores during Q4FY24 and the latter, on the other end, dipping from Rs 284 crores to Rs 220 crores.
As per the latest shareholding pattern data for the March’24 quarter, the Foreign Institutional Investors (FIIs) have consistently increased their stake in J K Cement Limited during FY24, recently increasing from 14.40 percent in Q2, 15.25 percent in Q3, and 15.92 percent in Q4.
Dr. Lal PathLabs Limited
With a market capitalization of Rs 21,246.78 crores, the stocks of Dr. Lal PathLabs Limited, one of India’s leading consumer healthcare brands in diagnostic services, started their trading session on Friday at Rs 2,539.90 and closed at Rs 2,545.20, gaining approximately 1.02 percent compared to the previous close of Rs 2,519.40 apiece.
During the recent financial quarters, the company’s basic business parameters, viz, its operating revenues as well as after-tax profits, reported a marginal jump in numbers with the former increasing from Rs 539 crores during Q3FY24 to Rs 545 crores during Q4FY24 and the latter, keeping the timeframe the same, rising from Rs 82 crores to Rs 86 crores.
As per the latest shareholding pattern data for the March’24 quarter, the Foreign Institutional Investors (FIIs) have consistently increased their stake in Dr. Lal PathLabs Limited during FY24, recently increasing from 24.35 percent in Q2, 25.36 percent in Q3, and 26.15 percent in Q4.
Birlasoft Limited
With a market capitalization of Rs 16,854.68 crores, the stocks of Birlasoft Limited, providing computer programming, consultancy, and other associated activities, started their trading session on Friday at Rs 617.25 and closed at Rs 610.50, slipping approximately 0.84 percent compared to the previous close of Rs 615.70 apiece.
During the recent financial quarters, the company’s basic business parameters, viz, its operating revenues as well as after-tax profits, reported a marginal jump in numbers with the former increasing from Rs 1,343 crores during Q3FY24 to Rs 1,363 crores during Q4FY24 and the latter, keeping the timeframe the same, rising from Rs 161 crores to Rs 180 crores.
As per the latest shareholding pattern data for the March’24 quarter, the Foreign Institutional Investors (FIIs) have consistently increased their stake in Birlasoft Limited during FY24, recently increasing from 17.57 percent in Q2, 21.25 percent in Q3, and 23.48 percent in Q4.
Written by Amit Madnani
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
